The worldwide high prevalence of chronic kidney disease (CKD) and the increasing number of patients reaching end-stage renal disease (ESRD) are a matter of major concern. The most widely accepted classification system of CKD is that proposed by the Kidney Disease Outcomes Quality Initiative (KDOQI) in 2002. When applying this system, it has become apparent that the prevalence of CKD is particularly high in elderly subjects. The fact that this system is mainly based on estimated glomerular filtration rate (eGFR), subdividing the severity of CKD into five stages, is a matter of debate. A main issue is that although a reduced eGFR is often encountered in elderly subjects, most of these subjects do not have a renal disease leading to an increased risk of ESRD, i.e. the predictive power of ESRD is unsatisfactory. Recent advances have been put forward to improve (1) estimation of GFR and (2) prediction of ESRD. In this review, we discuss the currently available data with a focus on the elderly and propose an improved classification system of CKD which is characterized by a substantially better diagnostic accuracy for progression to ESRD. This is simply and cost-effectively accomplished by subdividing stage 3 CKD into two groups (eGFR 30-44 and 45-59 ml/min/1.73 m(2)) and by complementing all levels of eGFR with information about urinary albumin excretion, i.e. whether normoalbuminuria, microalbuminuria, or macroalbuminuria is present. The consequence should be a revision of the 2002 KDOQI CKD classification system according to these findings, which would be a significant step forward, particularly for elderly CKD patients. Copyright (C) 2010 S. Karger AG, Basel
机构:
Univ Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England
Salford Royal NHS Trust, Renal Dept, Salford, Lancs, EnglandUniv Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England
Skarnpardoni, Sofia
Poulikakos, Dirnitrios
论文数: 0引用数: 0
h-index: 0
机构:
Univ Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England
Salford Royal NHS Trust, Renal Dept, Salford, Lancs, EnglandUniv Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England
Poulikakos, Dirnitrios
Malik, Marek
论文数: 0引用数: 0
h-index: 0
机构:
Imperial Coll, Natl Heart & Lung Inst, London, EnglandUniv Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England
Malik, Marek
Green, Darren
论文数: 0引用数: 0
h-index: 0
机构:
Univ Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England
Salford Royal NHS Trust, Renal Dept, Salford, Lancs, EnglandUniv Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England
Green, Darren
Kalra, Philip A.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England
Salford Royal NHS Trust, Renal Dept, Salford, Lancs, EnglandUniv Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England
机构:
Wm Jennings Bryan Dorn VA Med Ctr, Dept Med, Columbia, SC USAWm Jennings Bryan Dorn VA Med Ctr, Dept Med, Columbia, SC USA
Mathew, Roy O.
Bettinger, Jeffrey J.
论文数: 0引用数: 0
h-index: 0
机构:
Albany Coll Pharm & Hlth Sci, Dept Profess Practice, Albany, NY USAWm Jennings Bryan Dorn VA Med Ctr, Dept Med, Columbia, SC USA
Bettinger, Jeffrey J.
Wegrzyn, Erica L.
论文数: 0引用数: 0
h-index: 0
机构:
Albany Stratton VA Med Ctr, Dept Pharm, Albany, NY USAWm Jennings Bryan Dorn VA Med Ctr, Dept Med, Columbia, SC USA
Wegrzyn, Erica L.
Fudin, Jeffrey
论文数: 0引用数: 0
h-index: 0
机构:
Albany Stratton VA Med Ctr, Dept Pharm, Albany, NY USA
Remitigate LLC, Sci & Clin Affairs, Delmar, NY USAWm Jennings Bryan Dorn VA Med Ctr, Dept Med, Columbia, SC USA
机构:
Hosp Casa Sollievo della Sofferenza, Inst Sci, Rehabil Med & Neuro Rehabilitat Unit, San Giovanni Rotondo, Foggia, ItalyHosp Casa Sollievo della Sofferenza, Inst Sci, Rehabil Med & Neuro Rehabilitat Unit, San Giovanni Rotondo, Foggia, Italy
机构:
Stanford Univ, Div Nephrol, Sch Med, Palo Alto, CA 94304 USA
VA Palo Alto Healthcare Syst Geriatr Res Educ & C, Palo Alto, CA USAStanford Univ, Div Nephrol, Sch Med, Palo Alto, CA 94304 USA